Free alerts

LYEL insider buying

Every open-market purchase of Lyell Immunopharma, Inc. (LYEL) stock by its officers, directors and major shareholders, from SEC Form 4 filings.

Bought, last 12 months$25M
Insiders buying (12m)2
Purchases on record2
Last purchase filedMar 9, 2026

In the last 12 months, 2 insiders of Lyell Immunopharma, Inc. bought $25M of LYEL stock on the open market in 2 reported purchases. The most recent was filed on Mar 9, 2026: ARCH Venture Partners IX Overage, L.P. +4 (10% Owner) bought 488,090 shares at $25.61, worth $12.50M.

Get the next LYEL insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All LYEL insider purchases

FiledInsiderValueSharesPriceStakeTrade
Mar 9ARCH Venture Partners IX Over…10% Owner$12.50M488,090$25.61+52%Mar 6SEC
Mar 9Berns Paul L +810% Owner$12.50M488,090$25.61+52%Mar 6SEC